RxDoctor Payments Data

Monish Aron, MD

Urology · Los Angeles, CANPI 1033387345

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (29.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 79.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $5,004 and has fallen 95.6% since, to $218 in 2025.

$15,044in general payments, 2019–2025

Across 62 payments — averaging $242.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$12K
  • Histosonics, Inc.$2K
  • Medtronic$827
  • AbbVie$232
  • Johnson & Johnson$183
  • Procept Biorobotics Corporation$145
  • plus $102 from 3 others
$90,723in research payments, 2019–2025

Across 13 payments — averaging $6978.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$74K
  • Histosonics, Inc.$16K

What the payments were for

  • Speaking & faculty fees$4,00027%
  • Travel & lodging$3,60024%
  • Food & beverage$2,94420%
  • Education$4,50030%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical37$11,946
Histosonics, Inc.2$1,608
Medtronic10$827
AbbVie7$232
Johnson & Johnson2$183
Procept Biorobotics Corporation1$145
Axogen1$51
Immunitybio, Inc.1$27
Biotissue Holdings Inc.1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,044 in reported general payments places this provider in the 85th percentile of 1,324 urology providers in California.

See all urology providers in California →

Medicare billing

Part B allowed, 2024
$251,643
Medicare patients
642
Services billed
1,404

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl13$92

Paid to pharmacies, not to this prescriber.

Other urology in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →